Consumption of cranberry polyphenols enhances human γδ-T cell proliferation and reduces the number of symptoms associated with colds and influenza: a randomized, placebo-controlled intervention study

BACKGROUND: Our main objective was to evaluate the ability of cranberry phytochemicals to modify immunity, specifically γδ-T cell proliferation, after daily consumption of a cranberry beverage, and its effect on health outcomes related to cold and influenza symptoms. METHODS: The study was a randomi...

Full description

Saved in:
Bibliographic Details
Published inNutrition journal Vol. 12; no. 1; pp. 161 - 738
Main Authors Nantz, Meri P, Rowe, Cheryl A, Muller, Catherine, Creasy, Rebecca, Colee, James, Khoo, Christina, Percival, Susan S
Format Journal Article
LanguageEnglish
Published England Springer-Verlag 13.12.2013
BioMed Central Ltd
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BACKGROUND: Our main objective was to evaluate the ability of cranberry phytochemicals to modify immunity, specifically γδ-T cell proliferation, after daily consumption of a cranberry beverage, and its effect on health outcomes related to cold and influenza symptoms. METHODS: The study was a randomized, double-blind, placebo-controlled, parallel intervention. Subjects drank a low calorie cranberry beverage (450 ml) made with a juice-derived, powdered cranberry fraction (n = 22) or a placebo beverage (n = 23), daily, for 10 wk. PBMC were cultured for six days with autologous serum and PHA-L stimulation. Cold and influenza symptoms were self-reported. RESULTS: The proliferation index of γδ-T cells in culture was almost five times higher after 10 wk of cranberry beverage consumption (p <0.001). In the cranberry beverage group, the incidence of illness was not reduced, however significantly fewer symptoms of illness were reported (p = 0.031). CONCLUSIONS: Consumption of the cranberry beverage modified the ex vivo proliferation of γδ-T cells. As these cells are located in the epithelium and serve as a first line of defense, improving their function may be related to reducing the number of symptoms associated with a cold and flu. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01398150 .
Bibliography:http://dx.doi.org/10.1186/1475-2891-12-161
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1475-2891
1475-2891
DOI:10.1186/1475-2891-12-161